Search published articles


Showing 3 results for Type of Study: Editorial

, , ,
Volume 16, Issue 1 (6-2020)
Abstract

absterac absterac absterac
Samaneh Dehghani, Masud Yunesian,
Volume 19, Issue 4 (3-2024)
Abstract

Microplastics refer to plastic particles and fragments smaller than 5 millimeters in various forms, derived from the breakdown of larger plastics or initially introduced into the environment from the primary constituent particles of plastic. The exact date of the emergence of microplastics in the environment is not precisely known, but it certainly predates the naming of these particles (2004). These particles can enter the bodies of living organisms, including humans, primarily through ingestion and inhalation. Their effects on the body depend on their size, chemical composition, and the composition of substances that later absorb these particles. In this article, we will first briefly examine the classification of these particles in terms of chemical composition and their origins, and then review some evidence of their presence in biological tissues and fluids. Given the increasing production and use of plastics in human life and the fact that most microplastics in nature derive from the breakdown of larger plastics, sometimes several years after their disposal, it is expected that even if plastic production decreases or stops, we will continue to see an increase in their presence in nature for years and decades, leading to human exposure to these compounds (whose effects and consequences of this exposure are not yet fully understood).

Bahareh Yazdizadeh, Farid Najafi,
Volume 21, Issue 3 (12-2025)
Abstract

The World Health Organization has extended the roadmap for prevention and control of the Non-Communicable Diseases (NCDs) program, 2013–2020 until 2030. In the political declaration of the fourth meeting of the United Nations General Assembly held on September 25, 2025, the promotion of mental health and well-being has also been added to the agenda. The overarching goal of the program is to reduce premature mortality from non-communicable diseases by one-third by 2030 through prevention and control, as well as by promoting mental health and well-being. The program emphasizes the need to accelerate progress toward these goals through the implementation of a set of evidence-based, cost-effective, and affordable interventions. The role of national research systems is to generate the necessary evidence to identify best interventions, implement them, and monitor and evaluate their outcomes. This article identifies knowledge needs based on an evidence-informed policymaking approach. Within this framework, specific questions are defined for each stage of the policymaking cycle, which must be answered using evidence. Furthermore, the results of the mid-point evaluation of WHO’s 2013–2020 roadmap have been analyzed, and the identified research questions have been incorporated into those arising from the evidence-informed policymaking approach.


Page 1 from 1     

© 2026 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by : Yektaweb